Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status

Gutiérrez Aguirre, César Homero y Cantú Rodríguez, Olga Graciela y González Llano, Óscar y Salazar Riojas, R. y Martínez González, Odra Lizzette y Jaime Pérez, José Carlos y Gómez Almaguer, David (2005) Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status. Biology of Blood and Marrow Transplantation, 11 (2). pp. 61-62. ISSN 10838791

Vista previa

Texto
492.pdf
Download (75kB) | Vista previa

URL o página oficial: http://doi.org/10.1016/j.bbmt.2004.12.184

Resumen

Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult patients with good risk AML, allogeneic HSCT is usually indicated in second complete remission or first untreated relapse. We analyzed the outcome of 16 AML patients who received a reduced intensity conditioning regimen for allogeneic HSCT in first or second remission.

Tipo de elemento:

Article

Palabras claves no controlados:

Trasplante alogénico, Células madre, Leucemia mieloide aguda

Materias:

R Medicina > RD Cirugía

Divisiones:

Medicina

Usuario depositante:

Editor Repositorio

Creadores:

Creador	Email	ORCID
Gutiérrez Aguirre, César Homero	NO ESPECIFICADO	NO ESPECIFICADO
Cantú Rodríguez, Olga Graciela	NO ESPECIFICADO	NO ESPECIFICADO
González Llano, Óscar	NO ESPECIFICADO	NO ESPECIFICADO
Salazar Riojas, R.	NO ESPECIFICADO	NO ESPECIFICADO
Martínez González, Odra Lizzette	NO ESPECIFICADO	NO ESPECIFICADO
Jaime Pérez, José Carlos	NO ESPECIFICADO	NO ESPECIFICADO
Gómez Almaguer, David	dgomezalmaguer@gmail.com	orcid.org/0000-0002-0460-6427